Notice of Intent to Publish a Funding Opportunity Announcement for NCI Pathway to Independence Award (K99/R00 � Independent Clinical Trial Optional)
ID: 355537Type: Forecasted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355537
Timeline
    Description

    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the NCI Pathway to Independence Award (K99/R00), which includes an optional independent clinical trial component. This program aims to support the transition of talented postdoctoral researchers, who have up to six years of postdoctoral research training experience, into independent tenure-track faculty positions, thereby fostering a strong cohort of independent investigators in cancer research. The funding opportunity is significant as it provides essential support for awardees to establish competitive, independent research careers aligned with the mission of the National Cancer Institute (NCI). Interested applicants should note that the estimated synopsis post date is November 1, 2024, with a closing date for applications on February 14, 2025, and an anticipated award date of January 2, 2026.

    Point(s) of Contact
    No information provided.
    Files
    No associated files provided.
    Similar Opportunities
    NCI Pathway to Independence Award (K99/R00 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award (K99/R00), a federal grant aimed at supporting postdoctoral researchers in their transition to independent faculty positions, specifically in the field of cancer research. This program provides a structured funding mechanism over five years, consisting of a two-year mentored training phase (K99) followed by a three-year independent research phase (R00), with a focus on proposals that align with the NCI's mission. Eligible applicants include a diverse range of institutions, such as historically black colleges and universities, Hispanic-serving institutions, and other nonprofit entities, although candidates must not hold independent research faculty positions and should have no more than six years of postdoctoral experience. Interested applicants can find more information and submit their proposals starting January 27, 2025, with the application deadline set for October 14, 2027. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award (K99/R00), a federal grant designed to support postdoctoral researchers transitioning to independent faculty positions in cancer research. This program provides funding for up to five years, consisting of a two-year mentored phase (K99) followed by up to three years of independent research support (R00), contingent upon securing a tenure-track position. The initiative aims to foster a diverse and skilled workforce in biomedical research, addressing critical health needs while promoting the career development of emerging investigators. Interested applicants must hold a clinical or research doctorate and have no more than six years of postdoctoral experience at the time of application. The application period opens on January 13, 2025, with a submission deadline of October 14, 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-135.html.
    NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00), aimed at facilitating the transition of postdoctoral fellows into independent faculty positions in cancer research. This grant program is designed for researchers with doctoral degrees who require minimal additional mentored training, providing up to two years of support during the K99 phase followed by up to three years of independent research funding in the R00 phase. The initiative underscores NIH's commitment to strengthening the workforce in cancer research, particularly in areas such as cancer control and prevention, while ensuring that applicants present a comprehensive career development plan and mentorship strategy. Applications will open on January 14, 2024, with potential awards beginning in February 2024; interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00), aimed at facilitating the transition of postdoctoral fellows to independent faculty positions. This program is specifically designed for researchers with clinical or research doctoral degrees who require minimal additional mentored training and are proposing to lead independent clinical trials or studies. The award consists of two phases: the K99 phase provides up to $100,000 annually for two years of mentored research, followed by the R00 phase, which offers up to $249,000 per year for three years of independent research. Interested applicants must adhere to detailed submission guidelines and can find more information at the provided NIH link. The application deadline is October 14, 2026, and inquiries can be directed to grantsinfo@nih.gov.
    NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), is offering the K99/R00 Pathway to Independence Award aimed at supporting early-stage postdoctoral researchers transitioning to independent research positions. This funding opportunity is designed for postdoctoral fellows with research or clinical doctoral degrees, focusing on studies involving human participants that meet the NIH definitions of clinical trials and basic research, particularly in cancer control, prevention, and data sciences. The program consists of a two-phase structure: the K99 phase provides up to two years of mentored support, while the R00 phase offers up to three years of independent research funding, contingent on progress and securing a faculty position. Interested applicants must adhere to strict guidelines and institutional nominations, with key deadlines approaching in January 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-288.html.
    NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Pathway to Independence Award (K99/R00), a federal grant aimed at facilitating the transition of postdoctoral researchers into independent faculty positions. This program provides up to five years of support through two phases: the K99 phase offers up to two years of mentored training and research, while the R00 phase provides up to three years of independent research funding, contingent upon satisfactory progress and appointment to a qualifying faculty position. The initiative emphasizes the development of a diverse pool of skilled scientists and requires applicants to propose a significant research plan, establish a solid mentorship framework, and demonstrate institutional commitment to their career development. Interested applicants must submit their proposals by May 7, 2027, and can find additional information at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Pathway to Independence Award (K99/R00), a federal grant aimed at supporting postdoctoral researchers in their transition to independent faculty positions. This program is designed to provide up to five years of funding, divided into two phases: the K99 phase for mentored training and the R00 phase for independent research, specifically targeting individuals with no more than four years of postdoctoral experience. The initiative emphasizes the importance of cultivating a diverse and skilled workforce in biomedical and clinical research, encouraging applications from underrepresented groups. Interested applicants must submit their proposals by May 7, 2027, and can find additional information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    The NCI Transition Career Development Award (K22 Independent Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Transition Career Development Award (K22), a federal grant aimed at supporting researchers transitioning from mentored, non-independent positions to their first independent tenure-track faculty roles in cancer research. This grant provides funding for up to three years, covering both salary and research development expenses, with the goal of enhancing the applicant's potential to secure independent NIH grants and fostering a diverse pool of capable scientists in the biomedical field. Eligible applicants include various institutions and organizations, particularly those serving underrepresented groups, and must adhere to detailed application guidelines. Interested parties can find more information and apply before the closing date of November 12, 2025, by visiting the NIH grants website or contacting NIH Grants Information at grantsinfo@nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for Academic Career Excellence (ACE) Award (K32 - Independent Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Academic Career Excellence (ACE) Award (K32), which requires an independent clinical trial. This grant aims to support late-stage graduate students and early-stage postdoctoral scholars in cancer research, specifically targeting those transitioning to postdoctoral positions or within the first two years of their postdoctoral training. The ACE Award is crucial for enhancing the scientific research and career development of candidates, as it provides essential training support and encourages the development of a robust research plan with a designated mentor. Interested applicants should note that the first due date for submissions is anticipated to be June 12, 2025, with an estimated award date of March 2, 2026. For further details, applicants can refer to the NIH website or contact the agency directly.
    Notice of Intent to Publish a Funding Opportunity Announcement for Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Paul Calabresi Career Development Award for Clinical Oncology (K12), aimed at supporting institutional research career development programs for clinical scientists in cancer research. This initiative emphasizes training for clinical scientists who aspire to lead independent clinical trials or contribute to existing trials, thereby enhancing the field of clinical cancer research. The NOFO is anticipated to be released in November 2024, with the first application deadline set for February 2025, and the estimated award date is January 5, 2026. Interested applicants are encouraged to begin developing collaborations and applications in advance, as there are no cost-sharing requirements associated with this grant opportunity.